Elucidation of normal ovarian physiology by exogenous gondaotropin stimulation following steroid pituitary suppression.
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy; D006063:Chorionic Gonadotropin / Q000494:pharmacology*; D002996:Clomiphene / Q000627:therapeutic use; D003338:Corpus Luteum / Q000187:drug effects; D005260:Female; D005640:Follicle Stimulating Hormone / Q000494:pharmacology*; D006062:Gonadotropins / Q000627:therapeutic use; D006801:Humans; D007986:Luteinizing Hormone / Q000494:pharmacology*; D008656:Mestranol / Q000494:pharmacology*; D009640:Norethindrone / Q000494:pharmacology*; D010053:Ovary / Q000502:physiology*; D010900:Pituitary Diseases / Q000188:drug therapy; D010902:Pituitary Gland / Q000187:drug effects*; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy; D011247:Pregnancy
D006063:Chorionic Gonadotropin; D006062:Gonadotropins; D002996:Clomiphene; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008656:Mestranol; D009640:Norethindrone